South & Central America Overactive Bladder Treatment Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Pharmacotherapy (Anticholinergics, Mirabegron, Botox, Neurostimulation, and Intravesical Instillation) and Disease Type (Idiopathic Overactive Bladder and Neurogenic Bladder)

The South & Central America overactive bladder treatment market is expected to grow from US$ 472.49 million in 2022 to US$ 543.53 million by 2028; it is estimated to grow at a CAGR of 2.4% from 2022 to 2028.

Increasing Number of Mergers and Acquisitions is Propelling South & Central America Overactive Bladder Treatment Market Growth

Through mergers and acquisitions (M&A), companies can gain a competitive edge by entering new markets and acquiring new technologies. The ongoing mergers and acquisitions in the overactive bladder treatment market are creating growth opportunities for various companies. In July 2021, Uro Medical strengthened its urology portfolio with the acquisition of Micron Medical, which offers wirelessly powered, injectable, microtechnology neurostimulators focused on treating overactive bladder. These neurostimulators, which can be easily incorporated into patients’ daily lives, offer a convenient, safe, minimally invasive, and cost-effective urological treatment option. In February 2021, Axonics Modulation Technologies, Inc.—a medical technology company—acquired Contura Ltd. and its proprietary product, Bulkamid, which is a urethral bulking agent for women with stress urinary incontinence (SUI). Axonics produces and markets novel implantable sacral neuromodulation (SNM) devices for the treatment of urinary and bowel dysfunction. The acquisition of Contura Ltd. provides an opportunity to expand its SNM business across the world and serve the large, highly underpenetrated SUI market. The company plans to offer urogynecologists and urologists a complete suite of clinically differentiated incontinence solutions to treat their patients. Thus, increasing number of mergers and acquisitions is propelling South & Central America overactive bladder treatment market growth

South & Central America Overactive Bladder Treatment Market Overview

The South & Central America overactive bladder treatment market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil is expected to account for the largest share of the market in the region, and it is projected to register the highest CAGR during the forecast period. The market growth is attributed to the growing geriatric population and rising prevalence of chronic disorders. The region is witnessing the high prevalence of obesity, unhealthy lifestyle patterns, and other risks, which are contributing to overactive bladder syndrome. As a result, the awareness of overactive bladder treatment has increased across the region, which is influencing the market growth in the region.

South & Central America Overactive Bladder Treatment Market Revenue and Forecast to 2028 (US$ Million)

Get more information on this report :

South & Central America Overactive Bladder Treatment Market Segmentation

The South & Central America overactive bladder treatment market is segmented on the basis of pharmacotherapy, disease type, and country.

Based on pharmacotherapy, the South & Central America overactive bladder treatment market is segmented into anticholinergics, mirabegron, botox, neurostimulation, and intravesical instillation. The mirabegron segment registered the largest share of the market in 2022.

Based on disease type, the South & Central America overactive bladder treatment market is bifurcated into idiopathic overactive bladder and neurogenic bladder. The idiopathic overactive bladder segment held a larger share of the market in 2022.

Based on country, the South & Central America overactive bladder treatment market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the market in 2022.

AbbVie Inc; Astellas Pharma Inc; Endo Pharmaceuticals Inc.; Hisamitsu Pharmaceutical Co., Inc.; Medtronic Plc; Pfizer Inc; and Teva Pharmaceutical Industries Ltd are the leading companies operating in the South & Central America overactive bladder treatment market.

1. Introduction

1.1 Study Scope

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 South & Central America Overactive Bladder Treatment Market– By Pharmacotherapy

1.3.2 South & Central America Overactive Bladder Treatment Market– By Disease Type

1.3.3 South & Central America Overactive Bladder Treatment Market – By Country

2. South & Central America Overactive Bladder Treatment Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. South & Central America Overactive Bladder Treatment Market – Market Landscape

4.1 Overview

4.2 South & Central America PEST Analysis

4.3 Expert Opinion

5. South & Central America Overactive Bladder Treatment Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increase in Prevalence of Urinary Incontinence

5.1.2 Growing Incidence of Urinary Tract Infections

5.2 Key Market Restraints

5.2.1 Recalls of Therapeutic Drugs

5.3 Key Market Opportunities

5.3.1 Increasing Number of Mergers and Acquisitions

5.4 Future Trends

5.4.1 Robust Pipeline of Drugs and Successive Launch of Novel Therapies

5.5 Impact analysis

6. South & Central America Overactive Bladder Treatment Market – South & Central America Analysis

6.1 South & Central America Overactive Bladder Treatment Market Revenue Forecast and Analysis

7. South & Central America Overactive Bladder Treatment Market Analysis and Forecasts To 2028 – By Pharmacotherapy

7.1 Overview

7.2 South & Central America Overactive Bladder Treatment Market, By Pharmacotherapy 2021 & 2028 (%)

7.3 Mirabegron

7.3.1 Overview

7.3.2 Mirabegron: South & Central America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.4 Botox

7.4.1 Overview

7.4.2 Botox: South & Central America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.5 Neurostimulation

7.5.1 Overview

7.5.2 Neurostimulation: South & Central America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

7.5.3 Transcutaneous Sacral Nerve Stimulation

7.5.3.1 Overview

7.5.3.2 Transcutaneous Sacral Nerve Stimulation: South & Central America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

7.5.4 Transcutaneous Tibial Nerve Stimulation

7.5.4.1 Overview

7.5.4.2 Transcutaneous Tibial Nerve Stimulation: South & Central America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

7.5.5 Percutaneous Posterior Tibial Nerve Stimulation

7.5.5.1 Overview

7.5.5.2 Percutaneous Posterior Tibial Nerve Stimulation: South & Central America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

7.5.6 Others

7.5.6.1 Overview

7.5.6.2 Others: South & Central America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

7.6 Anticholinergics

7.6.1 Overview

7.6.2 Anticholinergics: South & Central America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.3 Solifenacin

7.6.3.1 Overview

7.6.3.2 Solifenacin: South & Central America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.4 Oxybutynin

7.6.4.1 Overview

7.6.4.2 Oxybutynin: South & Central America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.5 Fesoterodine

7.6.5.1 Overview

7.6.5.2 Fesoterodine: South & Central America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.6 Darifenacin

7.6.6.1 Overview

7.6.6.2 Darifenacin: South & Central America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.7 Tolterodine

7.6.7.1 Overview

7.6.7.2 Tolterodine: South & Central America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.8 Trospium

7.6.8.1 Overview

7.6.8.2 Trospium: South & Central America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.9 Other Anticholinergics

7.6.9.1 Overview

7.6.9.2 Other Anticholinergics: South & Central America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.7 Intravesical Instillation

7.7.1 Overview

7.7.2 Intravesical Instillation: South & Central America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

8. South & Central America Overactive Bladder Treatment Market Analysis and Forecasts To 2028 – By Disease Type

8.1 Overview

8.2 South & Central America Overactive Bladder Treatment Market, By Disease Type 2021 & 2028 (%)

8.3 Idiopathic Overactive Bladder

8.3.1 Overview

8.3.2 Idiopathic: Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

8.4 Neurogenic Overactive Bladder

8.4.1 Overview

8.4.2 Neurogenic: South & Central America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

9. Overactive Bladder Treatment Market Revenue and Forecasts to 2028 – Country Analysis

Overview

9.1.2 South & Central America: Overactive Bladder Treatment Market, by Country, 2021 & 2028 (%)

9.1.2.1 Brazil: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.2 Brazil: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.3 Brazil: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (USD Million)

9.1.2.3.1.1 Brazil: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)

9.1.2.3.1.2 Brazil Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)

9.1.2.4 Brazil: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (USD Million)

9.1.3 Argentina: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.1 Argentina: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.1.1 Argentina: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (USD Million)

9.1.3.1.1.1 Argentina: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)

9.1.3.1.1.2 Argentina Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)

9.1.3.1.2 Argentina: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (USD Million)

9.1.3.2 Rest of South & Central America: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.2.1 Rest of South & Central America: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.2.2 Rest of South & Central America: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (USD Million)

9.1.3.2.2.1 Rest of South & Central America: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)

9.1.3.2.2.2 Rest of South & Central America Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)

9.1.3.2.3 Rest of South & Central America: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (USD Million)

10. Overactive Bladder Treatment Market– Industry Landscape

10.1 Overview

10.2 Organic Developments

10.2.1 Overview

11. Company Profiles

11.1 Astellas Pharma Inc

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 AbbVie Inc

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Teva Pharmaceutical Industries Ltd

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Endo Pharmaceuticals Inc.

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 HiSouth & Central Americaitsu Pharmaceutical Co., Inc.

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Medtronic Plc

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 Pfizer Inc

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

12. Appendix

12.1 About The Insight Partners

12.2 Glossary of Terms

LIST OF TABLES

Table 1. Brazil Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (USD Million)

Table 2. Brazil Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)

Table 3. Brazil Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 4. Brazil Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)

Table 5. Argentina Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (USD Million)

Table 6. Argentina Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)

Table 7. Argentina Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 8. Argentina Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)

Table 9. Rest of South & Central America Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (USD Million)

Table 10. Rest of South & Central America Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)

Table 11. Rest of South & Central America Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 12. Rest of South & Central America Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)

Table 13. Organic Developments Done by Companies

Table 14. Glossary of Terms

LIST OF FIGURES

Figure 1. South & Central America Overactive Bladder Treatment Market Segmentation

Figure 2. South & Central America Overactive Bladder Treatment Market Segmentation, By Country

Figure 3. South & Central America Overactive Bladder Treatment Market Overview

Figure 4. Mirabegron Segment Held Largest Share by Pharmacotherapy in South & Central America Overactive Bladder Treatment market

Figure 5. Argentina Is Expected to Show Remarkable Growth During the Forecast Period

Figure 7. South & Central America: PEST Analysis

Figure 8. South & Central America Overactive Bladder Treatment Market: Impact Analysis of Driver and Restraints

Figure 9. South & Central America Overactive Bladder Treatment Market – Revenue Forecast and Analysis – 2019- 2028

Figure 10. South & Central America Overactive Bladder Treatment Market, by Pharmacotherapy 2021 & 2028 (%)

Figure 11. Mirabegron: South & Central America Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12. Botox: South & Central America Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13. Neurostimulation: South & Central America Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14. Transcutaneous Sacral Nerve Stimulation: South & Central America Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15. Transcutaneous Tibial Nerve Stimulation: South & Central America Overactive Bladder Market Revenue and Forecasts to 2028 (US$ MN)

Figure 16. Percutaneous Posterior Tibial Nerve: South & Central America Overactive Bladder Stimulation Market Revenue and Forecasts To 2028 (US$ MN)

Figure 17. Others: South & Central America Overactive Bladder Market Revenue and Forecasts To 2028 (US$ MN)

Figure 18. Anticholinergics: South & Central America Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19. Solifenacin: South & Central America Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 20. Oxybutynin: South & Central America Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21. Fesoterodine: South & Central America Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22. Darifenacin: South & Central America Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23. Tolterodine: South & Central America Overactive Bladder Market Revenue and Forecasts To 2028 (US$ Million)

Figure 24. Trospium: South & Central America Overactive Bladder Market Revenue and Forecasts To 2028 (US$ Million)

Figure 25. Other Anticholinergics: South & Central America Overactive Bladder Market Revenue and Forecasts To 2028 (US$ Million)

Figure 26. Intravesical Instillation: South & Central America Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 27. South & Central America Overactive Bladder Treatment Market, by Disease Type 2021 & 2028 (%)

Figure 28. Idiopathic: Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 29. Neurogenic: South & Central America Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 30. South & Central America: Overactive Bladder Treatment Market, by Key Country – Revenue (2021) (USD Million)

Figure 31. Brazil: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 32. Argentina: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 33. Rest of South & Central America: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South & Central America overactive bladder treatment market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the South & Central America overactive bladder treatment market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the overactive bladder treatment market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
South America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a..	May 2022
South and Central America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission,..	May 2022
South and Central America In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syring..	May 2022

Purchase Options

Single User License

$3000

$2400

Site License

$4000

$3200

Enterprise License

$5000